title: Young women with advanced aortoiliac occlusive disease: new insights.
abstract: We identified a group of 24 young (less than 50 years of age) women with isolated, premature atherosclerotic aortoiliac occlusive disease and attempted to identify distinguishing hemostatic characteristics. Most of these patients (62%) presented with acute thromboembolic events (blue toe syndrome, n = 6; macroemboli, n = 6; or aortoiliac thrombosis, n = 3). Aortoiliac reconstruction (aortoiliac endarterectomy, n = 10, aortobifurcation bypass grafts, n = 6; and percutaneous angioplasty, n = 4) was complicated by early thrombosis in 6 of 20 cases (30%), (1 of 10 endarterectomies, 4 of 6 bypass grafts, and 1 of 4 angioplasties). Fresh thrombus overlying an atherosclerotic plaque was a common finding at surgery. This observation and the relatively high incidence of thromboembolic events led us to hypothesize that a characteristic hemostatic profile might underlie the remarkably similar clinical presentations of these women. Levels of antiphospholipid antibodies (anticardiolipin antibodies and lupus anticoagulant), plasminogen activator inhibitor-1, fibrinogen, antithrombin III, protein C, protein S, plasminogen, prothrombin fragment F1 + 2, and D-dimer were determined for these young women and for 21 age-matched white female control subjects without vascular disease and nine white male patients with aortoiliac occlusive disease (mean 61 years, range 43 to 74 years). The incidence of anticardiolipin antibodies was 42% (8 of 19) in the female patients, which was significantly elevated (p = 0.028). The female (62.5%) and male (100%) patients had significantly elevated D-dimer levels (p < 0.001). Deficiencies of antithrombin III, protein C, and protein S were rare. A unique pattern of premature aortoiliac atherosclerosis exists in some young women. Intra-arterial thromboembolic events are common at presentation and complicate surgical management. The role of antiphospholipid antibodies remains uncertain.
authors.affiliation: Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Gagne
authors.forename: M J
authors.initials: MJ
authors.lastname: Vitti
authors.forename: L M
authors.initials: LM
authors.lastname: Fink
authors.forename: J
authors.initials: J
authors.lastname: Duncan
authors.forename: M L
authors.initials: ML
authors.lastname: Nix
authors.forename: R W
authors.initials: RW
authors.lastname: Barnes
authors.forename: M
authors.initials: M
authors.lastname: Hauer-Jensen
authors.forename: G W
authors.initials: GW
authors.lastname: Barone
authors.forename: J F
authors.initials: JF
authors.lastname: Eidt
mesh_terms: D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000032:analysis; D001018:Aortic Diseases / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D001161:Arteriosclerosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006487:Hemostasis; D006801:Humans; D007083:Iliac Artery; D008297:Male; D012189:Retrospective Studies
chemical_list: D017152:Antibodies, Antiphospholipid